BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 22816737)

  • 1. High-throughput sequencing analysis of the chromosome 7q32 deletion reveals IRF5 as a potential tumour suppressor in splenic marginal-zone lymphoma.
    Fresquet V; Robles EF; Parker A; Martinez-Useros J; Mena M; Malumbres R; Agirre X; Catarino S; Arteta D; Osaba L; Mollejo M; Hernandez-Rivas JM; Calasanz MJ; Daibata M; Dyer MJ; Prosper F; Vizcarra E; Piris MÁ; Oscier D; Martinez-Climent JA
    Br J Haematol; 2012 Sep; 158(6):712-26. PubMed ID: 22816737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Splenic marginal zone lymphoma: characterization of 7q deletion and its value in diagnosis.
    Watkins AJ; Huang Y; Ye H; Chanudet E; Johnson N; Hamoudi R; Liu H; Dong G; Attygalle A; McPhail ED; Law ME; Isaacson PG; de Leval L; Wotherspoon A; Du MQ
    J Pathol; 2010 Mar; 220(4):461-74. PubMed ID: 20077527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An integrated genomic and expression analysis of 7q deletion in splenic marginal zone lymphoma.
    Watkins AJ; Hamoudi RA; Zeng N; Yan Q; Huang Y; Liu H; Zhang J; Braggio E; Fonseca R; de Leval L; Isaacson PG; Wotherspoon A; McPhail ED; Dogan A; Du MQ
    PLoS One; 2012; 7(9):e44997. PubMed ID: 23028731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA losses in the frequently deleted region of 7q in SMZL.
    Ruiz-Ballesteros E; Mollejo M; Mateo M; Algara P; Martínez P; Piris MA
    Leukemia; 2007 Dec; 21(12):2547-9. PubMed ID: 17625607
    [No Abstract]   [Full Text] [Related]  

  • 5. Constitutive expression of the AP-1 transcription factors c-jun, junD, junB, and c-fos and the marginal zone B-cell transcription factor Notch2 in splenic marginal zone lymphoma.
    Trøen G; Nygaard V; Jenssen TK; Ikonomou IM; Tierens A; Matutes E; Gruszka-Westwood A; Catovsky D; Myklebost O; Lauritzsen G; Hovig E; Delabie J
    J Mol Diagn; 2004 Nov; 6(4):297-307. PubMed ID: 15507668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A narrow deletion of 7q is common to HCL, and SMZL, but not CLL.
    Andersen CL; Gruszka-Westwood A; Østergaard M; Koch J; Jacobsen E; Kjeldsen E; Nielsen B
    Eur J Haematol; 2004 Jun; 72(6):390-402. PubMed ID: 15128417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prevalence of IG translocations and 7q32 deletions in splenic marginal zone lymphoma.
    Remstein ED; Law M; Mollejo M; Piris MA; Kurtin PJ; Dogan A
    Leukemia; 2008 Jun; 22(6):1268-72. PubMed ID: 17989713
    [No Abstract]   [Full Text] [Related]  

  • 8. Splenic marginal zone lymphoma: Clinical clustering of immunoglobulin heavy chain repertoires.
    Arcaini L; Zibellini S; Passamonti F; Rattotti S; Lucioni M; Invernizzi R; Merli M; Rizzi S; Boveri E; Rumi E; Astori C; Picone C; Varettoni M; Pascutto C; Paulli M; Lazzarino M
    Blood Cells Mol Dis; 2009; 42(3):286-91. PubMed ID: 19250848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular characterization of the region 7q22.1 in splenic marginal zone lymphomas.
    Robledo C; García JL; Benito R; Flores T; Mollejo M; Martínez-Climent JÁ; García E; Gutiérrez NC; Piris MA; Hernández JM
    PLoS One; 2011; 6(9):e24939. PubMed ID: 21957467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 7q31-32 allelic loss is a frequent finding in splenic marginal zone lymphoma.
    Mateo M; Mollejo M; Villuendas R; Algara P; Sanchez-Beato M; Martínez P; Piris MA
    Am J Pathol; 1999 May; 154(5):1583-9. PubMed ID: 10329610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Splenic B-cell lymphomas with more than 55% prolymphocytes in blood: evidence for prolymphocytoid transformation.
    Hoehn D; Miranda RN; Kanagal-Shamanna R; Lin P; Medeiros LJ
    Hum Pathol; 2012 Nov; 43(11):1828-38. PubMed ID: 22520947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deletion mapping on the long arm of chromosome 7 in splenic lymphoma with villous lymphocytes.
    Gruszka-Westwood AM; Hamoudi R; Osborne L; Matutes E; Catovsky D
    Genes Chromosomes Cancer; 2003 Jan; 36(1):57-69. PubMed ID: 12461750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dysregulation of cyclin dependent kinase 6 expression in splenic marginal zone lymphoma through chromosome 7q translocations.
    Corcoran MM; Mould SJ; Orchard JA; Ibbotson RE; Chapman RM; Boright AP; Platt C; Tsui LC; Scherer SW; Oscier DG
    Oncogene; 1999 Nov; 18(46):6271-7. PubMed ID: 10597225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Whole exome sequencing identifies novel recurrently mutated genes in patients with splenic marginal zone lymphoma.
    Parry M; Rose-Zerilli MJ; Gibson J; Ennis S; Walewska R; Forster J; Parker H; Davis Z; Gardiner A; Collins A; Oscier DG; Strefford JC
    PLoS One; 2013; 8(12):e83244. PubMed ID: 24349473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-resolution genome-wide array comparative genomic hybridization in splenic marginal zone B-cell lymphoma.
    Novara F; Arcaini L; Merli M; Passamonti F; Zibellini S; Rizzi S; Rattotti S; Rumi E; Pascutto C; Vetro A; Astori C; Boveri E; Lucioni M; Paulli M; Zuffardi O; Lazzarino M
    Hum Pathol; 2009 Nov; 40(11):1628-37. PubMed ID: 19647853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clonally related splenic marginal zone lymphoma and Hodgkin lymphoma with unmutated V gene rearrangements and a 15-yr time gap between diagnoses.
    Rosenquist R; Roos G; Erlanson M; Küppers R; Bräuninger A; Hansmann ML
    Eur J Haematol; 2004 Sep; 73(3):210-4. PubMed ID: 15287919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dysregulation of global microRNA expression in splenic marginal zone lymphoma and influence of chronic hepatitis C virus infection.
    Peveling-Oberhag J; Crisman G; Schmidt A; Döring C; Lucioni M; Arcaini L; Rattotti S; Hartmann S; Piiper A; Hofmann WP; Paulli M; Küppers R; Zeuzem S; Hansmann ML
    Leukemia; 2012 Jul; 26(7):1654-62. PubMed ID: 22307176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytogenetic aberrations and their prognostic value in a series of 330 splenic marginal zone B-cell lymphomas: a multicenter study of the Splenic B-Cell Lymphoma Group.
    Salido M; Baró C; Oscier D; Stamatopoulos K; Dierlamm J; Matutes E; Traverse-Glehen A; Berger F; Felman P; Thieblemont C; Gesk S; Athanasiadou A; Davis Z; Gardiner A; Milla F; Ferrer A; Mollejo M; Calasanz MJ; Florensa L; Espinet B; Luño E; Wlodarska I; Verhoef G; García-Granero M; Salar A; Papadaki T; Serrano S; Piris MA; Solé F
    Blood; 2010 Sep; 116(9):1479-88. PubMed ID: 20479288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Splenic marginal zone lymphomas are characterized by loss of interstitial regions of chromosome 7q, 7q31.32 and 7q36.2 that include the protection of telomere 1 (POT1) and sonic hedgehog (SHH) genes.
    Vega F; Cho-Vega JH; Lennon PA; Luthra MG; Bailey J; Breeden M; Jones D; Medeiros LJ; Luthra R
    Br J Haematol; 2008 Jun; 142(2):216-26. PubMed ID: 18492102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Splenic marginal zone lymphomas presenting with splenomegaly and typical immunophenotype are characterized by allelic loss in 7q31-32.
    Boonstra R; Bosga-Bouwer A; van Imhoff GW; Krause V; Palmer M; Coupland RW; Dabbagh L; van den Berg E; van den Berg A; Poppema S
    Mod Pathol; 2003 Dec; 16(12):1210-7. PubMed ID: 14681321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.